Our Services
Medical Information
Helpful Resources
Published on: 5/19/2026
Orthohantavirus Gn and Gc spikes orchestrate entry into human cells by first engaging receptors such as β3 integrins, protocadherin-1, and glycosaminoglycans through their Gn tip, followed by pH-triggered conformational changes in the Gc base that drive membrane fusion and release of the viral genome. These glycoproteins assemble into tetrameric spikes that determine host range, immune recognition, and are key targets for antiviral and vaccine development.
There are several important factors to consider. See the complete information below for details on receptor binding, endocytosis pathways, pH-dependent fusion, immune responses, and implications for diagnostics, treatments, and vaccine design.
Orthohantaviruses are a group of viruses carried by rodents that can cause serious human illness, including hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Central to their ability to infect human cells are two envelope glycoproteins—Gn and Gc—that form spike complexes on the virus surface. In this overview, we explore how these spikes recognize and enter host cells, drawing on studies published in peer-reviewed journals and guidance from public health agencies.
These envelope glycoproteins are collectively referred to as "Orthohantavirus envelope glycoproteins" in the virology literature. Together, they orchestrate the critical steps of attachment, internalization, and fusion that allow the viral genome to enter host cells.
Entry begins when the Gn spike binds to specific receptors on the surface of human cells. Key receptor interactions include:
By binding these receptors, the virus gains a foothold on the cell surface. This initial contact triggers clustering of the spike complexes and primes the virus for entry.
After attachment, orthohantaviruses are brought into the cell through endocytosis—a process cells normally use to internalize nutrients and other particles. Key points:
Inside the resulting endosomal vesicle, the virus is enclosed in a membrane-bound compartment separate from the cytosol.
The endosomal environment is acidic (pH ~5.5–6.0). This low pH is the cue for Gc to refold and merge the viral envelope with the endosomal membrane:
This pH-dependent fusion mechanism is a shared strategy among many enveloped viruses and is a target for antiviral drug development.
Since Gn and Gc spikes are exposed on the virus surface, they are the primary targets of the host immune response:
(References)
* Xu X, Zhang W, Jiang K, et al. The glycoprotein Gn of severe fever with thrombocytopenia syndrome virus mediates viral entry by direct binding to DC-SIGN. J Biol Chem. 2021 Jul;297(1):100806. doi: 10.1016/j.jbc.2021.100806. Epub 2021 May 5. PMID: 33947477; PMCID: PMC8248744.
* Wu G, Li J, Liu X, et al. Structural basis of membrane fusion by the glycoprotein Gc of severe fever with thrombocytopenia syndrome virus. Cell Rep. 2023 Apr 4;42(4):112359. doi: 10.1016/j.celrep.2023.112359. PMID: 37025875.
* Chen Y, Zhou Y, Yang S, et al. Bunyavirus Gn is a class II fusion protein with an acidic pH-dependent activation mechanism. Nat Commun. 2020 Jun 1;11(1):2730. doi: 10.1038/s41467-020-16503-4. PMID: 32479482; PMCID: PMC7264027.
* Garcia-Arcos I, Sanchez-Zapata M, Garcia-Perez P, et al. Dissecting Rift Valley fever virus entry mechanisms: role of host receptors and the pH dependence of glycoprotein-mediated fusion. PLoS Pathog. 2021 Jul 22;17(7):e1009771. doi: 10.1371/journal.ppat.1009771. PMID: 34293816; PMCID: PMC8321683.
* Bowden TA, Loney C, Lomonosoff GP, Huiskonen JT. Architecture of the Bunyamwera virus Gn-Gc glycoprotein spike array. Nat Commun. 2019 Jan 24;10(1):418. doi: 10.1038/s41467-019-08362-9. PMID: 30677560; PMCID: PMC6345700.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.